Enabling increased, sustainable, and coordinated clinical trials in Africa.
What is CTCAN?
The Clinical Trials Community Africa Network (CTCAN) is a network for clinical research stakeholders in Africa that seeks to enable increased, sustainable, and coordinated clinical trials on the continent. The network will build on the progress of the Clinical Trials Community (CTC) platform, which was created to increase the visibility of African clinical trialists and sites while contributing increase in clinical trial investments in Africa.
Main Objectives of CTCAN
The CTCAN project will thereby contribute to creating an environment that sustainably brings more trials to ​Africa, including large scale clinical trials and disease outbreak response activities.
Objective One
Develop an umbrella sub-Saharan African (SSA) ​network consolidating relevant subnetworks of ​clinical trial sites and laboratories,
Objective Three
Develop a framework to develop capacity and increase ​clinical trial preparedness,​
Objective Two
Supplement the network with ​epidemiological data associated with the ​sites and laboratories, and clear and ​operationalised regulatory information ​required for clinical trial start-up and ​conduct,
Objective Four
Develop a framework to develop capacity and increase ​clinical trial preparedness,​
Enhancing Capacity for SRA-Quality Trials through CTCAN
Many potential clinical sites in Africa need to develop additional capacity before they can take part in Stringent Regulatory Authority (SRA) - quality clinical trials. By entering the Clinical Trials Community Africa Network (CTCAN), sites and laboratories will be able to access a clinical trial preparedness framework. Through the proposed capability development activities, sites and laboratories will be strengthened to generate SRA-quality data, which in turn will be informative for new policies and practices, and lead to earlier access to new treatments.
​
While governmental and non-governmental organisations (NGOs), pharmaceutical companies, and other public-private sector actors have established important capacity development programmes in Africa,
​
CTCAN draws the different programmes and data together in, or linked to, a single platform.
Alignment between these Africa-led programmes and clinical research programmes of clinical trials sponsors will ultimately create a greater, sustainable, and cost-effective impact
Working with the best
Consortium Partners
Networks of Excellence
